MAPK1 and cardiac hypertrophy: Interestingly, at least in some settings, FHL1 and FHL2 appear to have differential effects on cardiac myocyte ERK activity [31,32], raising the possibility that the ERK pathway may be critical in mediating the regulation of cardiac hypertrophy by FHL proteins.